MedCity News

Capital Rx Expands Into Care Navigation with Acquisition of Amino Health

Bristol Myers Squibb Is Paying $350M to Expand Its Reach in Radiopharmaceuticals to Prostate Cancer

Bristol Myers Squibb is licensing global rights to a Philochem program in development for both diagnostic imaging and targeted treatment of prostate cancer. It follows the pharma giant’s entry into radiopharmaceuticals via the $4.1 billion acquisition of RayzeBio last year.

By Frank Vinluan

Policy

‘We Dissent’: NIH Workers Protest Trump Policies That ‘Harm the Health of Americans’

The letter is an extraordinary rebuke of the Trump administration’s actions against the NIH, which include: terminating hundreds of grants funding scientific and biomedical research; firing more than 1,000 employees this year; and moving to end billions in funds to partner institutions overseas.

By Rachana Pradhan

MedCity Influencers

Managing Routine Radiology: An Opportunity to Control Costs and Improve Care

Managing routine radiology does not require the administrative burden of prior authorization. Instead, health plans can implement post-service, pre-payment automated management based on clinical guidelines.

By Jim Koger and Mark Hiatt

Latest News

MedCity Influencers

Harnessing Real-World Data and AI to Advance Research and Treatment for Benign Prostatic Hyperplasia

The ability to harness real-world insights at scale empowers life sciences companies and clinicians to develop more targeted therapies, improve patient outcomes, and drive evidence-based innovation in BPH treatment.

By Sujay Jadhav

Legal

Why CVS, Express Scripts Are Suing Over the Arkansas PBM Law

Arkansas became the first state to pass a law banning pharmacy benefit managers from owning pharmacies, aiming to curb their market power and reduce drug costs. But major PBMs like CVS and Express Scripts are suing, claiming the law is unconstitutional.

By Marissa Plescia

The Role of Consultants in Tackling Healthcare Expenses

To ensure effective cost mitigation, employers can’t wait for the market to adjust — they have to punch first.

By Cole Harris - CBIZ

Hospitals Health Tech,

Virtual Nursing Saves Hospitals Money on Turnover Costs, Ardent Health CMO Says

Ardent Health is deploying virtual nurse technology to ease workflow burdens on bedside nurses by offloading routine tasks — and its nurse turnover rate has dropped from 15.5% to 9.5%. The health system is also using virtual specialty consults to enhance care in rural hospitals, cutting unnecessary transfers by 85% and enabling more patients to receive quality care close to home.

By Katie Adams

MedCity Influencers

Making Insurance Cover IVF Could Actually Reduce Access

President Trump’s plan to fix IVF might look bold in a headline. In reality, it doesn’t create a single new embryology lab. It doesn’t hire one more specialist. It won’t change the fact that right now, only people with plenty of money can afford IVF, and throwing subsidies at a market that’s already bottlenecked only shifts who pays.

By Hans Gangeskar

MedCity Influencers

Overlooked in the Overdose Crisis: Addressing Substance Use Treatment for Asian American, Native Hawaiian, and Pacific Islander Communities

Researchers and policymakers must challenge the default framing and stereotypical minority myth mindset which uniformly classifies AANHPI communities as low-risk, hindering both visibility and resource allocation.

By Imeth Illamperuma, Suhanee Mitragotri and David T. Zhu

Health Tech

Serve You Rx Adds 2 Stelara Biosimilars to Formulary to Help Patients Save Costs

In partnership with Cost Plus Drugs and Waltz Health, Serve You Rx has added Stelara biosimilars Otulfi and Yesintek to its formulary.

By Marissa Plescia

MedCity Influencers

How Healthcare Can Reduce Cybersecurity Response Times from Hours to Minutes

When an attack or other issue occurs, the main difference between being down for months versus minutes or a day is having a mature and tested incident response plan. Without a plan, your cybersecurity team is flying blind, resulting in confusion and inefficiency that significantly slows your response time.

By Preston Duren

MedCity Influencers

The Hidden Cost of Disconnected Quality Systems: Why Hospitals Should Modernize Now

The case for modernization isn’t solely about improving efficiency. It’s about equipping hospitals with the resources necessary to manage risk proactively, respond to negative trends quickly, and prioritize patient safety with high reliability.

By Michelle Hilburn

Hospitals, Providers

Hospitals See Financial Gains Due to Higher Volumes & Improved Throughput

Hospitals saw improved financial performance during the first four months of the year, with operating margins rising to 3.3% thanks to higher patient volumes and more efficient throughput. However, experts warn that hospitals remain financially vulnerable as non-labor expenses continue to rise.

By Katie Adams

Health Tech

Amazon Pharmacy Brings PillPack to Medicare and Adds Caregiver Feature — Will It Make a Difference?

Amazon Pharmacy recently launched a new caregiver feature and expanded PillPack to Medicare Part D. The company says the updates will support medication adherence.

By Marissa Plescia

BioPharma, Pharma

J&J’s Growth Strategy in Lung Cancer Borrows From Its Experience in Multiple Myeloma

Johnson & Johnson has projected its lung cancer drug Rybrevant could achieve $5 billion in peak revenue. At the recent ASCO annual meeting, J&J executive Joshua Bauml explained his company’s strategy for this drug in lung cancer and beyond.

By Frank Vinluan

Hospitals, Startups, Health Tech, Payers, Providers

From left to right: Colby Takeda (CEO of Pear Suite) and Arundhati Parmar (Editor-in-Chief of MedCity News)

INVEST Pitch Perfect Spotlight: How Pear Suite Makes Sure Community Health Workers Get Paid

Pear Suite recently won the payer/provider technology track of MedCity News’ INVEST Pitch Perfect contest. The startup provides a software platform for community health workers that helps them share data, submit claims and maintain compliance.

By Katie Adams

Policy

Debunked Episode 16: Will Trump Administration’s Drug Pricing Policies Lead to the End of PBMs?

UH Group replaces its CEO, the payer's alleged nursing home practices, the future of pharmacy benefit managers, and the healthcare implications of the budget bill are part of the latest episode of the Debunked Podcast with MedCity News Editor-in-Chief Arundhati Parmar and Samir Batra, managing partner of Health Innovation Pitch.

By Stephanie Baum

MedCity Influencers

The Behavioral Health AI Boom Is Real. So Are the Risks

Behavioral health doesn’t need tech that replaces people. It needs technology that respects them, amplifying what clinicians do best and helping more people get the care they deserve.

By Melissa Tran and Dr. Heidi V. Carlson

MedCity Influencers

A CIO’s Guide to Scalable Patient Data Management

Healthcare technology has shifted from a back-office function to a strategic imperative. This evolution presents a powerful opportunity to redefine organizations’ futures.

By Paul Hudec